CHARTING THE PATH TO
Magellan Bioanalytics generates human health data from analysis of the "hidden proteome”, a fraction of human serum that contains >30,000 potential biomarkers. Our proprietary technology has successfully identified biomarkers that predict or stage disease in various indications, from breast cancer to Alzheimer's.
Our current partnerships discussions are centered around identifying biomarkers that guide Alzheimer's drug development, and markers that predict patient response to cancer immunotherapy.
We are actively looking at additional partners to leverage our technology in other areas of human health.
Salt Lake City
5201 Green St, Suite 160
Salt Lake City, UT 84123
3156 Vista Way, Suite 220
Oceanside, CA 92056